Latest Capital Raising News

Uvre Limited has completed a strategic acquisition of New Zealand gold projects, commenced maiden drilling at its flagship Waitekauri site, and secured a dual listing on the NZX, positioning itself for significant exploration advances.

Zeotech Limited has locked in a $204 million binding offtake agreement for its kaolin products and successfully demonstrated its AusPozz™ low-carbon metakaolin in a large-scale concrete pour, signaling strong momentum in its commercialisation efforts.

Auris Minerals advances its exploration efforts in Western Australia's Bryah Basin with a $3.2 million strategic placement, aiming to expand its geological team and accelerate copper, gold, and rare earth project identification.

Syrah Resources reported resumed production at its Balama graphite mine and ongoing qualification delays at its Vidalia anode material facility, while US tariffs on Chinese graphite reshape global supply chains.

New Murchison Gold Limited has officially transitioned to a gold producer with first ore crushed and shipped from its Crown Prince Gold Mine, backed by strong exploration results and a successful $15 million capital raise.

Microba Life Sciences reports a 145% jump in core microbiome test volumes and is on track to achieve regional break-even by FY26, supported by strategic cost cuts and a $14.5 million capital raise.

Hillgrove Resources has accelerated production at its Nugent centre ahead of schedule, driving an 8% rise in copper output and reducing costs. A $28 million capital raise will fund further development and exploration, underpinning growth prospects.

X2M Connect Limited kicks off FY26 with a 25% revenue surge and a significant reduction in net debt, backed by major new contracts across Asia and the Middle East.

AdAlta Limited has completed the final share issuance under its Investment Agreement with the Meurs Group, securing the full $700,000 investment that bolstered its cellular immunotherapy development.

Liontown Resources delivered a robust September quarter with a significant ramp-up in underground mining at Kathleen Valley, alongside a fortified cash position and strategic contract amendments.

AdAlta Limited has made significant progress in its 'East to West' cellular immunotherapy strategy, advancing licensing negotiations for its first CAR-T product and raising $1.6 million through placements to bolster its financial position.

Peel Mining has secured $21.25 million through a placement and share purchase plan, while appointing a new leadership team to drive a strategic pivot focused on unlocking value from its copper and polymetallic assets in the Cobar Basin.